A study from NHS Digital – data from which were reported on the BBC website in 20161 – showed that there had been a 33% increase in admissions for different forms of allergy and an increase of 19% of cases of anaphylactic shock in hospital facilities in the UK in the preceding five years.
And the UK is not alone in this, in that a significant increase in the incidence of allergies has been registered in developed countries, first beginning in the 1960s and steadily progressing thereafter.
Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.